{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:07:08Z","timestamp":1765040828574},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11938-018-0194-y","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T02:23:56Z","timestamp":1539829436000},"page":"428-440","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Update on the Prevention of Post-ERCP Pancreatitis"],"prefix":"10.1007","volume":"16","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Buxbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"issue":"3","key":"194_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","volume":"37","author":"PB Cotton","year":"1991","unstructured":"Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383\u201393.","journal-title":"Gastrointest Endosc"},{"issue":"10035","key":"194_CR2","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/S0140-6736(16)30310-5","volume":"387","author":"H Luo","year":"2016","unstructured":"\u2022\u2022 Luo H, Zhao L, Leung J, Zhang R, Liu Z, Wang X, et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet. 2016;387(10035):2293\u2013301. \n https:\/\/doi.org\/10.1016\/S0140-6736(16)30310-5\n \n . In this very large randomized trial, indomethacin use in unselected patients decreased the risk of PEP supporting its use in all risk patients.","journal-title":"Lancet"},{"issue":"3","key":"194_CR3","first-page":"188","volume":"13","author":"AY Wang","year":"2017","unstructured":"Wang AY. Medications and methods for the prevention of post-ERCP pancreatitis. Gastroenterol Hepatol (N Y). 2017;13(3):188\u201391.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"1","key":"194_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.gie.2014.06.045","volume":"81","author":"B Kochar","year":"2015","unstructured":"Kochar B, Akshintala VS, Afghani E, Elmunzer BJ, Kim KJ, Lennon AM, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81(1):143\u20139 e9. \n https:\/\/doi.org\/10.1016\/j.gie.2014.06.045\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"194_CR5","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/gut.2007.140756","volume":"57","author":"BJ Elmunzer","year":"2008","unstructured":"Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57(9):1262\u20137. \n https:\/\/doi.org\/10.1136\/gut.2007.140756\n \n .","journal-title":"Gut"},{"issue":"3","key":"194_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.gie.2006.10.021","volume":"65","author":"YK Cheon","year":"2007","unstructured":"Cheon YK, Cho KB, Watkins JL, McHenry L, Fogel EL, Sherman S, et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc. 2007;65(3):385\u201393. \n https:\/\/doi.org\/10.1016\/j.gie.2006.10.021\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"194_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3109\/00365521.2014.894120","volume":"49","author":"J Halttunen","year":"2014","unstructured":"Halttunen J, Meisner S, Aabakken L, Arnelo U, Gronroos J, Hauge T, et al. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. 2014;49(6):752\u20138. \n https:\/\/doi.org\/10.3109\/00365521.2014.894120\n \n .","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"194_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1067\/mge.2001.117550","volume":"54","author":"ML Freeman","year":"2001","unstructured":"Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425\u201334.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"194_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ajg.2008.5","volume":"104","author":"P Wang","year":"2009","unstructured":"Wang P, Li ZS, Liu F, Ren X, Lu NH, Fan ZN, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104(1):31\u201340. \n https:\/\/doi.org\/10.1038\/ajg.2008.5\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"194_CR10","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/ajg.2010.136","volume":"105","author":"PA Testoni","year":"2010","unstructured":"Testoni PA, Mariani A, Giussani A, Vailati C, Masci E, Macarri G, et al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol. 2010;105(8):1753\u201361. \n https:\/\/doi.org\/10.1038\/ajg.2010.136\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"194_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.17219\/acem\/66773","volume":"27","author":"Y Tryliskyy","year":"2018","unstructured":"Tryliskyy Y, Bryce GJ. Post-ERCP pancreatitis: pathophysiology, early identification and risk stratification. Adv Clin Exp Med. 2018;27(1):149\u201354. \n https:\/\/doi.org\/10.17219\/acem\/66773\n \n .","journal-title":"Adv Clin Exp Med"},{"issue":"7","key":"194_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJMoa1213557","volume":"369","author":"S Zeuzem","year":"2013","unstructured":"Zeuzem S, Soriano V, Asselah T, Bronowicki JP, Lohse AW, Mullhaupt B, et al. Faldaprevir and deleobuvir for HCV genotype 1 infection. N Engl J Med. 2013;369(7):630\u20139. \n https:\/\/doi.org\/10.1056\/NEJMoa1213557\n \n .","journal-title":"N Engl J Med"},{"issue":"7","key":"194_CR13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.gie.2007.02.055","volume":"65","author":"G Manes","year":"2007","unstructured":"Manes G, Ardizzone S, Lombardi G, Uomo G, Pieramico O, Porro GB. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc. 2007;65(7):982\u20137. \n https:\/\/doi.org\/10.1016\/j.gie.2007.02.055\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"194_CR14","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0016-5085(98)70031-9","volume":"115","author":"PR Tarnasky","year":"1998","unstructured":"Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998;115(6):1518\u201324.","journal-title":"Gastroenterology"},{"issue":"15","key":"194_CR15","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","volume":"366","author":"BJ Elmunzer","year":"2012","unstructured":"Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366(15):1414\u201322. \n https:\/\/doi.org\/10.1056\/NEJMoa1111103\n \n .","journal-title":"N Engl J Med"},{"issue":"1","key":"194_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1572-0241.2006.00380.x","volume":"101","author":"CL Cheng","year":"2006","unstructured":"Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101(1):139\u201347. \n https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00380.x\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"194_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJM199609263351301","volume":"335","author":"ML Freeman","year":"1996","unstructured":"Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909\u201318. \n https:\/\/doi.org\/10.1056\/NEJM199609263351301\n \n .","journal-title":"N Engl J Med"},{"issue":"1","key":"194_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gie.2008.10.039","volume":"70","author":"PB Cotton","year":"2009","unstructured":"Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12\u00a0years. Gastrointest Endosc. 2009;70(1):80\u20138. \n https:\/\/doi.org\/10.1016\/j.gie.2008.10.039\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"194_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.surge.2014.11.005","volume":"13","author":"X Ding","year":"2015","unstructured":"Ding X, Zhang F, Wang Y. Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis. Surgeon. 2015;13(4):218\u201329. \n https:\/\/doi.org\/10.1016\/j.surge.2014.11.005\n \n .","journal-title":"Surgeon"},{"issue":"10","key":"194_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1055\/s-2003-42,614","volume":"35","author":"E Masci","year":"2003","unstructured":"Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003;35(10):830\u20134. \n https:\/\/doi.org\/10.1055\/s-2003-42,614\n \n .","journal-title":"Endoscopy"},{"issue":"2","key":"194_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.gie.2009.09.024","volume":"71","author":"AA Bailey","year":"2010","unstructured":"Bailey AA, Bourke MJ, Kaffes AJ, Byth K, Lee EY, Williams SJ. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis (with video). Gastrointest Endosc. 2010;71(2):266\u201371. \n https:\/\/doi.org\/10.1016\/j.gie.2009.09.024\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"194_CR22","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.cgh.2015.06.035","volume":"13","author":"P Sundaralingam","year":"2015","unstructured":"Sundaralingam P, Masson P, Bourke MJ. Early precut sphincterotomy does not increase risk during endoscopic retrograde cholangiopancreatography in patients with difficult biliary access: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2015;13(10):1722\u20139 e2. \n https:\/\/doi.org\/10.1016\/j.cgh.2015.06.035\n \n .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"194_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1053\/j.gastro.2004.07.017","volume":"127","author":"JA Disario","year":"2004","unstructured":"Disario JA, Freeman ML, Bjorkman DJ, Macmathuna P, Petersen BT, Jaffe PE, et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004;127(5):1291\u20139.","journal-title":"Gastroenterology"},{"issue":"8","key":"194_CR24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1572-0241.2004.30151.x","volume":"99","author":"TH Baron","year":"2004","unstructured":"Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol. 2004;99(8):1455\u201360. \n https:\/\/doi.org\/10.1111\/j.1572-0241.2004.30151.x\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"9059","key":"194_CR25","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0140-6736(96)11026-6","volume":"349","author":"JJ Bergman","year":"1997","unstructured":"Bergman JJ, Rauws EA, Fockens P, van Berkel AM, Bossuyt PM, Tijssen JG, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet. 1997;349(9059):1124\u20139. \n https:\/\/doi.org\/10.1016\/S0140-6736(96)11026-6\n \n .","journal-title":"Lancet"},{"issue":"5","key":"194_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.gie.2009.04.042","volume":"70","author":"S Jeong","year":"2009","unstructured":"Jeong S, Ki SH, Lee DH, Lee JI, Lee JW, Kwon KS, et al. Endoscopic large-balloon sphincteroplasty without preceding sphincterotomy for the removal of large bile duct stones: a preliminary study. Gastrointest Endosc. 2009;70(5):915\u201322. \n https:\/\/doi.org\/10.1016\/j.gie.2009.04.042\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"46","key":"194_CR27","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.3748\/wjg.v19.i46.8580","volume":"19","author":"JH Kim","year":"2013","unstructured":"Kim JH, Yang MJ, Hwang JC, Yoo BM. Endoscopic papillary large balloon dilation for the removal of bile duct stones. World J Gastroenterol. 2013;19(46):8580\u201394. \n https:\/\/doi.org\/10.3748\/wjg.v19.i46.8580\n \n .","journal-title":"World J Gastroenterol"},{"issue":"4","key":"194_CR28","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s10620-012-2494-8","volume":"58","author":"SJ Park","year":"2013","unstructured":"Park SJ, Kim JH, Hwang JC, Kim HG, Lee DH, Jeong S, et al. Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci. 2013;58(4):1100\u20139. \n https:\/\/doi.org\/10.1007\/s10620-012-2494-8\n \n .","journal-title":"Dig Dis Sci"},{"key":"194_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-230X-13-15","volume":"13","author":"JC Hwang","year":"2013","unstructured":"Hwang JC, Kim JH, Lim SG, Kim SS, Shin SJ, Lee KM, et al. Endoscopic large-balloon dilation alone versus endoscopic sphincterotomy plus large-balloon dilation for the treatment of large bile duct stones. BMC Gastroenterol. 2013;13:15. \n https:\/\/doi.org\/10.1186\/1471-230X-13-15\n \n .","journal-title":"BMC Gastroenterol"},{"key":"194_CR30","doi-asserted-by":"publisher","unstructured":"Krill JT, DaVee T, Edwards JS, Slaughter JC, Yachimski PS. Risk of postendoscopic retrograde cholangiopancreatography pancreatitis after double-guidewire biliary cannulation in an average-risk population. Pancreas. 2018; \n https:\/\/doi.org\/10.1097\/MPA.0000000000001070\n \n .","DOI":"10.1097\/MPA.0000000000001070"},{"issue":"9","key":"194_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1097\/MPA.0000000000000912","volume":"46","author":"EJ Kim","year":"2017","unstructured":"Kim EJ, Cho JH, Oh KY, Kim SY, Kim YS. The risk factors for moderately severe and severe post-endoscopic retrograde cholangiopancreatography pancreatitis according to the revised atlanta classification. Pancreas. 2017;46(9):1208\u201313. \n https:\/\/doi.org\/10.1097\/MPA.0000000000000912\n \n .","journal-title":"Pancreas"},{"issue":"7","key":"194_CR32","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/S0016-5085(03)00384-6","volume":"124","author":"B Murray","year":"2003","unstructured":"Murray B, Carter R, Imrie C, Evans S, O\u2019Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2003;124(7):1786\u201391.","journal-title":"Gastroenterology"},{"key":"194_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12876-015-0314-2","volume":"15","author":"VF Andrade-Davila","year":"2015","unstructured":"Andrade-Davila VF, Chavez-Tostado M, Davalos-Cobian C, Garcia-Correa J, Montano-Loza A, Fuentes-Orozco C, et al. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial. BMC Gastroenterol. 2015;15:85. \n https:\/\/doi.org\/10.1186\/s12876-015-0314-2\n \n .","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"194_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/MCG.0000000000000168","volume":"49","author":"A Patai","year":"2015","unstructured":"Patai A, Solymosi N, Patai AV. Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation: results from a randomized study with sequential biliary intubation. J Clin Gastroenterol. 2015;49(5):429\u201337. \n https:\/\/doi.org\/10.1097\/MCG.0000000000000168\n \n .","journal-title":"J Clin Gastroenterol"},{"key":"194_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1027530","volume":"2018","author":"Lei-Min Yu","year":"2018","unstructured":"Yu LM, Zhao KJ, Lu B. Use of NSAIDs via the rectal route for the prevention of pancreatitis after ERCP in all-risk patients: an updated meta-analysis. Gastroenterol Res Pract. 2018;2018:1027530. doi:\n https:\/\/doi.org\/10.1155\/2018\/1027530\n \n .","journal-title":"Gastroenterology Research and Practice"},{"key":"194_CR36","doi-asserted-by":"publisher","first-page":"46650","DOI":"10.1038\/srep46650","volume":"7","author":"YC Hou","year":"2017","unstructured":"Hou YC, Hu Q, Huang J, Fang JY, Xiong H. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis. Sci Rep. 2017;7:46650. \n https:\/\/doi.org\/10.1038\/srep46650\n \n .","journal-title":"Sci Rep"},{"issue":"5","key":"194_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.pan.2017.07.008","volume":"17","author":"C Yang","year":"2017","unstructured":"Yang C, Zhao Y, Li W, Zhu S, Yang H, Zhang Y, et al. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: an updated meta-analysis of randomized controlled trials. Pancreatology. 2017;17(5):681\u20138. \n https:\/\/doi.org\/10.1016\/j.pan.2017.07.008\n \n .","journal-title":"Pancreatology"},{"issue":"9","key":"194_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1055\/s-0034-1,377,875","volume":"46","author":"JM Dumonceau","year":"2014","unstructured":"Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014. Endoscopy. 2014;46(9):799\u2013815. \n https:\/\/doi.org\/10.1055\/s-0034-1,377,875\n \n .","journal-title":"Endoscopy"},{"issue":"1","key":"194_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","volume":"85","author":"V Chandrasekhara","year":"2017","unstructured":"\u2022\u2022 Committee ASoP, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85(1):32\u201347. \n https:\/\/doi.org\/10.1016\/j.gie.2016.06.051\n \n . Guidelines by the ASGE on techniques in the prevention of PEP.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"194_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/MPA.0000000000000326","volume":"44","author":"T Rustagi","year":"2015","unstructured":"Rustagi T, Njei B. Factors affecting the efficacy of nonsteroidal anti-inflammatory drugs in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Pancreas. 2015;44(6):859\u201367. \n https:\/\/doi.org\/10.1097\/MPA.0000000000000326\n \n .","journal-title":"Pancreas"},{"issue":"6","key":"194_CR41","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.gie.2007.04.012","volume":"66","author":"YK Cheon","year":"2007","unstructured":"Cheon YK, Cho KB, Watkins JL, McHenry L, Fogel EL, Sherman S, et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc. 2007;66(6):1126\u201332. \n https:\/\/doi.org\/10.1016\/j.gie.2007.04.012\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"194_CR42","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cgh.2014.11.038","volume":"13","author":"NM Kubiliun","year":"2015","unstructured":"Kubiliun NM, Adams MA, Akshintala VS, Conte ML, Cote GA, Cotton PB, et al. Evaluation of pharmacologic prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review. Clin Gastroenterol Hepatol. 2015;13(7):1231\u20139; quiz e70\u20131. \n https:\/\/doi.org\/10.1016\/j.cgh.2014.11.038\n \n .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"194_CR43","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/MPA.0000000000000852","volume":"46","author":"K Kato","year":"2017","unstructured":"Kato K, Shiba M, Kakiya Y, Maruyama H, Ominami M, Fukunaga S, et al. Celecoxib oral administration for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized prospective trial. Pancreas. 2017;46(7):880\u20136. \n https:\/\/doi.org\/10.1097\/MPA.0000000000000852\n \n .","journal-title":"Pancreas"},{"issue":"4","key":"194_CR44","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1053\/j.gastro.2015.12.040","volume":"150","author":"John M. Levenick","year":"2016","unstructured":"\u2022\u2022 Levenick JM, Gordon SR, Fadden LL, Levy LC, Rockacy MJ, Hyder SM, et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients. Gastroenterology. 2016;150(4):911\u20137; quiz e19. \n https:\/\/doi.org\/10.1053\/j.gastro.2015.12.040\n \n . This interventional trial of rectal indomethacin in unselected patients suggests a lack of benefit for PEP prevention in an average risk population.","journal-title":"Gastroenterology"},{"issue":"3","key":"194_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1053\/j.gastro.2016.05.055","volume":"151","author":"BJ Elmunzer","year":"2016","unstructured":"Elmunzer BJ, Foster LD, Durkalski V. Should we still administer prophylactic rectal NSAIDs to average-risk patients undergoing ERCP? Gastroenterology. 2016;151(3):566\u20137. \n https:\/\/doi.org\/10.1053\/j.gastro.2016.05.055\n \n .","journal-title":"Gastroenterology"},{"issue":"2","key":"194_CR46","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1053\/j.gastro.2016.04.048","volume":"151","author":"NR Thiruvengadam","year":"2016","unstructured":"\u2022 Thiruvengadam NR, Forde KA, Ma GK, Ahmad N, Chandrasekhara V, Ginsberg GG, et al. Rectal indomethacin reduces pancreatitis in high- and low-risk patients undergoing endoscopic retrograde cholangiopancreatography. Gastroenterology. 2016;151(2):288\u201397 e4. \n https:\/\/doi.org\/10.1053\/j.gastro.2016.04.048\n \n . This large observational trial suggests that rectal indomethacin is effective in preventing PEP in patients with diverse risk profiles.","journal-title":"Gastroenterology"},{"issue":"1","key":"194_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12876-017-0599-4","volume":"17","author":"J Wan","year":"2017","unstructured":"Wan J, Ren Y, Zhu Z, Xia L, Lu N. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis. BMC Gastroenterol. 2017;17(1):43. \n https:\/\/doi.org\/10.1186\/s12876-017-0599-4\n \n .","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"194_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-0031-1,291,440","volume":"44","author":"P Katsinelos","year":"2012","unstructured":"Katsinelos P, Fasoulas K, Paroutoglou G, Chatzimavroudis G, Beltsis A, Terzoudis S, et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy. 2012;44(1):53\u20139. \n https:\/\/doi.org\/10.1055\/s-0031-1,291,440\n \n .","journal-title":"Endoscopy"},{"issue":"16","key":"194_CR49","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2169\/internalmedicine.0554-17","volume":"57","author":"Mitsuru Okuno","year":"2018","unstructured":"Okuno M, Shiroko J, Taguchi D, Yamaguchi K, Takada J, Imai S, et al. The Effectiveness of the rectal administration of low-dose diclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Intern Med. 2018; \n https:\/\/doi.org\/10.2169\/internalmedicine.0554-17\n \n .","journal-title":"Internal Medicine"},{"issue":"3","key":"194_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MEG.0000000000000787","volume":"29","author":"AH Mohammad Alizadeh","year":"2017","unstructured":"Mohammad Alizadeh AH, Abbasinazari M, Hatami B, Abdi S, Ahmadpour F, Dabir S, et al. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. Eur J Gastroenterol Hepatol. 2017;29(3):349\u201354. \n https:\/\/doi.org\/10.1097\/MEG.0000000000000787\n \n .","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"194_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10620-008-0709-9","volume":"55","author":"LM Shao","year":"2010","unstructured":"Shao LM, Chen QY, Chen MY, Cai JT. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci. 2010;55(1):1\u20137. \n https:\/\/doi.org\/10.1007\/s10620-008-0709-9\n \n .","journal-title":"Dig Dis Sci"},{"issue":"1","key":"194_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/00365521.2016.1228117","volume":"52","author":"P Katsinelos","year":"2017","unstructured":"Katsinelos P, Lazaraki G, Chatzimavroudis G, Katsinelos T, Georgakis N, Anastasiadou K, et al. Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis. Scand J Gastroenterol. 2017;52(1):50\u20135. \n https:\/\/doi.org\/10.1080\/00365521.2016.1228117\n \n .","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"194_CR53","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.gie.2010.09.022","volume":"73","author":"T Seta","year":"2011","unstructured":"Seta T, Noguchi Y. Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis. Gastrointest Endosc. 2011;73(4):700\u20136 e1\u20132. \n https:\/\/doi.org\/10.1016\/j.gie.2010.09.022\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"194_CR54","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1055\/s-0034-1377306","volume":"46","author":"M Concepcion-Martin","year":"2014","unstructured":"Concepcion-Martin M, Gomez-Oliva C, Juanes A, Diez X, Prieto-Alhambra D, Torras X, et al. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial. Endoscopy. 2014;46(10):851\u20136. \n https:\/\/doi.org\/10.1055\/s-0034-1377306\n \n .","journal-title":"Endoscopy"},{"key":"194_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fphar.2016.00489","volume":"7","author":"J Hu","year":"2016","unstructured":"Hu J, Li PL, Zhang T, Chen JP, Hu YJ, Yu Z, et al. Role of somatostatin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: an update meta-analysis. Front Pharmacol. 2016;7:489. \n https:\/\/doi.org\/10.3389\/fphar.2016.00489\n \n .","journal-title":"Front Pharmacol"},{"issue":"4","key":"194_CR56","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.pan.2018.03.002","volume":"18","author":"Guiliang Wang","year":"2018","unstructured":"Wang G, Xiao G, Xu L, Qiu P, Li T, Wang X, et al. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: a systematic review and meta-analysis. Pancreatology. 2018; \n https:\/\/doi.org\/10.1016\/j.pan.2018.03.002\n \n .","journal-title":"Pancreatology"},{"issue":"6","key":"194_CR57","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0016-5107(95)70014-5","volume":"42","author":"GR Weiner","year":"1995","unstructured":"Weiner GR, Geenen JE, Hogan WJ, Catalano MF. Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc. 1995;42(6):579\u201383.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"194_CR58","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1572-0241.1999.999_u.x","volume":"94","author":"GD Palma De","year":"1999","unstructured":"De Palma GD, Catanzano C. Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol. 1999;94(4):982\u20135. \n https:\/\/doi.org\/10.1111\/j.1572-0241.1999.999_u.x\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"194_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1067\/mge.2003.307","volume":"58","author":"S Sherman","year":"2003","unstructured":"Sherman S, Blaut U, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc. 2003;58(1):23\u20139. \n https:\/\/doi.org\/10.1067\/mge.2003.307\n \n .","journal-title":"Gastrointest Endosc"},{"key":"194_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-230X-8-6","volume":"8","author":"M Zheng","year":"2008","unstructured":"Zheng M, Bai J, Yuan B, Lin F, You J, Lu M, et al. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis. BMC Gastroenterol. 2008;8:6. \n https:\/\/doi.org\/10.1186\/1471-230X-8-6\n \n .","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"194_CR61","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.gie.2009.08.007","volume":"70","author":"J Cheung","year":"2009","unstructured":"Cheung J, Tsoi KK, Quan WL, Lau JY, Sung JJ. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc. 2009;70(6):1211\u20139. \n https:\/\/doi.org\/10.1016\/j.gie.2009.08.007\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"194_CR62","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/ajg.2009.269","volume":"104","author":"V Cennamo","year":"2009","unstructured":"Cennamo V, Fuccio L, Zagari RM, Eusebi LH, Ceroni L, Laterza L, et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104(9):2343\u201350. \n https:\/\/doi.org\/10.1038\/ajg.2009.269\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"194_CR63","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/ajg.2016.268","volume":"111","author":"J Buxbaum","year":"2016","unstructured":"Buxbaum J, Leonor P, Tung J, Lane C, Sahakian A, Laine L. Randomized trial of endoscopist-controlled vs. assistant-controlled wire-guided cannulation of the bile duct. Am J Gastroenterol. 2016;111(12):1841\u20137. \n https:\/\/doi.org\/10.1038\/ajg.2016.268\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"194_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0042-119,035","volume":"49","author":"F Tse","year":"2017","unstructured":"Tse F, Yuan Y, Moayyedi P, Leontiadis GI, Barkun AN. Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2017;49(1):15\u201326. \n https:\/\/doi.org\/10.1055\/s-0042-119,035\n \n .","journal-title":"Endoscopy"},{"issue":"2","key":"194_CR65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.gie.2010.10.039","volume":"73","author":"A Choudhary","year":"2011","unstructured":"Choudhary A, Bechtold ML, Arif M, Szary NM, Puli SR, Othman MO, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73(2):275\u201382. \n https:\/\/doi.org\/10.1016\/j.gie.2010.10.039\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"194_CR66","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00535-013-0806-1","volume":"49","author":"T Mazaki","year":"2014","unstructured":"Mazaki T, Mado K, Masuda H, Shiono M. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014;49(2):343\u201355. \n https:\/\/doi.org\/10.1007\/s00535-013-0806-1\n \n .","journal-title":"J Gastroenterol"},{"issue":"2","key":"194_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.gie.2007.06.022","volume":"67","author":"AM Saad","year":"2008","unstructured":"Saad AM, Fogel EL, McHenry L, Watkins JL, Sherman S, Lazzell-Pannell L, et al. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. Gastrointest Endosc. 2008;67(2):255\u201361. \n https:\/\/doi.org\/10.1016\/j.gie.2007.06.022\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"194_CR68","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.gie.2006.07.031","volume":"65","author":"A Das","year":"2007","unstructured":"Das A, Singh P, Sivak MV Jr, Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc. 2007;65(7):960\u20138. \n https:\/\/doi.org\/10.1016\/j.gie.2006.07.031\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"194_CR69","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/s-0030-1,255,781","volume":"42","author":"T Mazaki","year":"2010","unstructured":"Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2010;42(10):842\u201353. \n https:\/\/doi.org\/10.1055\/s-0030-1,255,781\n \n .","journal-title":"Endoscopy"},{"issue":"1","key":"194_CR70","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13063-018-2583-x","volume":"19","author":"X Smeets","year":"2018","unstructured":"\u2022\u2022 Smeets X, da Costa DW, Fockens P, Mulder CJJ, Timmer R, Kievit W, et al. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial. Trials. 2018;19(1):207. \n https:\/\/doi.org\/10.1186\/s13063-018-2583-x\n \n . The paper described a very large ongoing multicenter RCT in the Netherlands evaluating the combination of rectal NSAIDS with different fluid strategies for PEP prevention.","journal-title":"Trials"},{"issue":"5","key":"194_CR71","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/bjs.5316","volume":"93","author":"CM Cuthbertson","year":"2006","unstructured":"Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg. 2006;93(5):518\u201330. \n https:\/\/doi.org\/10.1002\/bjs.5316\n \n .","journal-title":"Br J Surg"},{"issue":"2 Pt 1","key":"194_CR72","doi-asserted-by":"publisher","first-page":"G346","DOI":"10.1152\/ajpgi.1991.260.2.G346","volume":"260","author":"K Kusterer","year":"1991","unstructured":"Kusterer K, Enghofer M, Zendler S, Blochle C, Usadel KH. Microcirculatory changes in sodium taurocholate-induced pancreatitis in rats. Am J Physiol. 1991;260(2 Pt 1):G346\u201351. \n https:\/\/doi.org\/10.1152\/ajpgi.1991.260.2.G346\n \n .","journal-title":"Am J Physiol"},{"issue":"2","key":"194_CR73","doi-asserted-by":"publisher","first-page":"303-307.e1","DOI":"10.1016\/j.cgh.2013.07.026","volume":"12","author":"James Buxbaum","year":"2014","unstructured":"Buxbaum J, Yan A, Yeh K, Lane C, Nguyen N, Laine L. Aggressive hydration with lactated Ringer\u2019s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 2014;12(2):303\u2013307 e1. doi:\n https:\/\/doi.org\/10.1016\/j.cgh.2013.07.026\n \n .","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"194_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cgh.2016.06.007","volume":"15","author":"JH Choi","year":"2017","unstructured":"\u2022 Choi JH, Kim HJ, Lee BU, Kim TH, Song IH. Vigorous periprocedural hydration with lactated ringer\u2019s solution reduces the Risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients. Clin Gastroenterol Hepatol. 2017;15(1):86\u201392 e1. \n https:\/\/doi.org\/10.1016\/j.cgh.2016.06.007\n \n . This is a double-blinded RCT trial which suggests that aggressive hydration with LR is effective for PEP prevention.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"194_CR75","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/gut.2008.148551","volume":"57","author":"MD Noble","year":"2008","unstructured":"Noble MD, Romac J, Vigna SR, Liddle RA. A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis. Gut. 2008;57(11):1566\u201371. \n https:\/\/doi.org\/10.1136\/gut.2008.148551\n \n .","journal-title":"Gut"},{"issue":"3","key":"194_CR76","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1053\/j.gastro.2009.05.041","volume":"137","author":"M Bhoomagoud","year":"2009","unstructured":"Bhoomagoud M, Jung T, Atladottir J, Kolodecik TR, Shugrue C, Chaudhuri A, et al. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastroenterology. 2009;137(3):1083\u201392. \n https:\/\/doi.org\/10.1053\/j.gastro.2009.05.041\n \n .","journal-title":"Gastroenterology"},{"issue":"8","key":"194_CR77","doi-asserted-by":"publisher","first-page":"710-717.e1","DOI":"10.1016\/j.cgh.2011.04.026","volume":"9","author":"Bechien U. Wu","year":"2011","unstructured":"Wu BU, Hwang JQ, Gardner TH, Repas K, Delee R, Yu S et al. Lactated Ringer\u2019s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol 2011;9(8):710\u2013717 e1. doi:\n https:\/\/doi.org\/10.1016\/j.cgh.2011.04.026\n \n .","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"194_CR78","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-0043-122,386","volume":"50","author":"CH Park","year":"2018","unstructured":"Park CH, Paik WH, Park ET, Shim CS, Lee TY, Kang C, et al. Aggressive intravenous hydration with lactated Ringer\u2019s solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial. Endoscopy. 2018;50(4):378\u201385. \n https:\/\/doi.org\/10.1055\/s-0043-122,386\n \n .","journal-title":"Endoscopy"},{"issue":"3","key":"194_CR79","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/MCG.0000000000000781","volume":"51","author":"ZF Zhang","year":"2017","unstructured":"Zhang ZF, Duan ZJ, Wang LX, Zhao G, Deng WG. Aggressive hydration with lactated ringer solution in prevention of postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis o f randomized controlled trials. J Clin Gastroenterol. 2017;51(3):e17\u201326. \n https:\/\/doi.org\/10.1097\/MCG.0000000000000781\n \n .","journal-title":"J Clin Gastroenterol"},{"issue":"9","key":"194_CR80","doi-asserted-by":"publisher","first-page":"838","DOI":"10.4103\/1735-1995.170597","volume":"20","author":"A Shaygan-Nejad","year":"2015","unstructured":"Shaygan-Nejad A, Masjedizadeh AR, Ghavidel A, Ghojazadeh M, Khoshbaten M. Aggressive hydration with Lactated Ringer\u2019s solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled double-blind clinical trial. J Res Med Sci. 2015;20(9):838\u201343. \n https:\/\/doi.org\/10.4103\/1735-1995.170597\n \n .","journal-title":"J Res Med Sci"},{"issue":"15","key":"194_CR81","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1056\/NEJM199610103351501","volume":"335","author":"SM Hammer","year":"1996","unstructured":"Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. N Engl J Med. 1996;335(15):1081\u201390. \n https:\/\/doi.org\/10.1056\/NEJM199610103351501\n \n .","journal-title":"N Engl J Med"},{"issue":"1","key":"194_CR82","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13063-016-1251-2","volume":"17","author":"BJ Elmunzer","year":"2016","unstructured":"\u2022\u2022 Elmunzer BJ, Serrano J, Chak A, Edmundowicz SA, Papachristou GI, Scheiman JM, et al. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2016;17(1):120. \n https:\/\/doi.org\/10.1186\/s13063-016-1251-2\n \n . This is the study protocol of a large multicenter RCT comparing the combination of pancreatic stent and rectal indomethacin versus rectal indomethacin alone which aims to inform the use of pancreatitic stents for PEP prevention.","journal-title":"Trials"},{"issue":"6","key":"194_CR83","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/ajg.2014.9","volume":"109","author":"R Sotoudehmanesh","year":"2014","unstructured":"Sotoudehmanesh R, Eloubeidi MA, Asgari AA, Farsinejad M, Khatibian M. A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am J Gastroenterol. 2014;109(6):903\u20139. \n https:\/\/doi.org\/10.1038\/ajg.2014.9\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"194_CR84","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.gie.2014.07.033","volume":"81","author":"NS Choksi","year":"2015","unstructured":"Choksi NS, Fogel EL, Cote GA, Romagnuolo J, Elta GH, Scheiman JM, et al. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest Endosc. 2015;81(1):150\u20135. \n https:\/\/doi.org\/10.1016\/j.gie.2014.07.033\n \n .","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"194_CR85","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ajg.2012.442","volume":"108","author":"BJ Elmunzer","year":"2013","unstructured":"Elmunzer BJ, Higgins PD, Saini SD, Scheiman JM, Parker RA, Chak A, et al. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol. 2013;108(3):410\u20135. \n https:\/\/doi.org\/10.1038\/ajg.2012.442\n \n .","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"194_CR86","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.gie.2016.10.033","volume":"85","author":"SRS Mok","year":"2017","unstructured":"Mok SRS, Ho HC, Shah P, Patel M, Gaughan JP, Elfant AB. Lactated Ringer\u2019s solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointest Endosc. 2017;85(5):1005\u201313. \n https:\/\/doi.org\/10.1016\/j.gie.2016.10.033\n \n .","journal-title":"Gastrointest Endosc"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-018-0194-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-018-0194-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-018-0194-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T23:25:25Z","timestamp":1571354725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-018-0194-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1007\/s11938-018-0194-y","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"assertion":[{"value":"18 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}]}}